Cargando…

Patient preferences for treatment modalities for localised prostate cancer

OBJECTIVES: To assess the patient preferences and utility scores for the different conventional and innovative treatment modalities for localised prostate cancer (PCa). SUBJECTS AND METHODS: Patients treated for localised PCa and healthy volunteers were invited to fill out a treatment‐outcome scenar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teunissen, Frederik R., Hehakaya, Charisma, Meijer, Richard P., van Melick, Harm H. E., Verkooijen, Helena M., van der Voort van Zyp, Jochem R. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931535/ https://www.ncbi.nlm.nih.gov/pubmed/36816141 http://dx.doi.org/10.1002/bco2.198

Ejemplares similares

The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

Problems and Promises of Introducing the Magnetic Resonance Imaging Linear Accelerator Into Routine Care: The Case of Prostate Cancer
por: Hehakaya, Charisma, et al.
Publicado: (2020)

Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients
por: Teunissen, Frederik R., et al.
Publicado: (2021)

Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

Implementation of Magnetic Resonance Imaging-Guided Radiation Therapy in Routine Care: Opportunities and Challenges in the United States
por: Hehakaya, Charisma, et al.
Publicado: (2022)

Realizing the value of complex medical technology: Demonstrating cost-effectiveness is not enough
por: Hehakaya, C., et al.
Publicado: (2023)

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy
por: Maspero, Matteo, et al.
Publicado: (2018)

Deep learning for automated contouring of neurovascular structures on magnetic resonance imaging for prostate cancer patients
por: van den Berg, Ingeborg, et al.
Publicado: (2023)

Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer
por: Teunissen, F.R., et al.
Publicado: (2021)

Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives
por: van Son, Marieke, et al.
Publicado: (2018)

Health-related quality of life after ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: reporting the patient’s perspective
por: van Son, Marieke, et al.
Publicado: (2020)

Perineal recurrence of prostate cancer six years after trans-perineal brachytherapy
por: Eppinga, Wietse, et al.
Publicado: (2014)

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study
por: Willigenburg, Thomas, et al.
Publicado: (2020)

Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients
por: van Son, Marieke, et al.
Publicado: (2020)

Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy
por: Peters, Max, et al.
Publicado: (2016)

Fast and accurate deformable contour propagation for intra-fraction adaptive magnetic resonance-guided prostate radiotherapy
por: Willigenburg, Thomas, et al.
Publicado: (2022)

Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer
por: Van Son, Marieke J, et al.
Publicado: (2018)

Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator
por: Willigenburg, Thomas, et al.
Publicado: (2021)

The Development and External Validation of Artificial Intelligence-Driven MRI-Based Models to Improve Prediction of Lesion-Specific Extraprostatic Extension in Patients with Prostate Cancer
por: van den Berg, Ingeborg, et al.
Publicado: (2023)

Clinical implementation of MRI-based organs-at-risk auto-segmentation with convolutional networks for prostate radiotherapy
por: Savenije, Mark H. F., et al.
Publicado: (2020)

Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review
por: Duijzentkunst, D. A. Smit, et al.
Publicado: (2016)

On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy
por: de Muinck Keizer, Daan M., et al.
Publicado: (2021)

Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator
por: den Hartogh, Mariska D., et al.
Publicado: (2019)

Tolerability of concurrent external beam radiotherapy and [(177)Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)
por: van der Sar, Esmée C. A., et al.
Publicado: (2023)

Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system
por: Kontaxis, Charis, et al.
Publicado: (2020)

Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Willigenburg, Thomas, et al.
Publicado: (2021)

Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors
por: Strohm, Lea, et al.
Publicado: (2020)

Superfast Magnetic Resonance Imaging-based Diagnostic Pathway for Prostate Cancer
por: Paulino Pereira, Leonor Jane, et al.
Publicado: (2022)

Localisation of epileptic foci using novel imaging modalities
por: De Ciantis, Alessio, et al.
Publicado: (2013)

Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study
por: Ahmed, Hashim U, et al.
Publicado: (2012)

MRI‐based synthetic CT shows equivalence to conventional CT for the morphological assessment of the hip joint
por: Florkow, Mateusz C., et al.
Publicado: (2021)

Fast contour propagation for MR‐guided prostate radiotherapy using convolutional neural networks
por: Eppenhof, K.A.J., et al.
Publicado: (2020)

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—Referee
por: van den Bergh, Roderick C.N., et al.
Publicado: (2021)

Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative
por: Reesink, Daan J., et al.
Publicado: (2021)

Current Trends in the Management of Localised Prostate Cancer
por: Sibley, G. N. A., et al.
Publicado: (1992)

Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer
por: van Moorselaar, R. Jeroen A., et al.
Publicado: (2022)

Hand preference for the visual and auditory modalities in humans
por: Yang, Yuqian, et al.
Publicado: (2021)

Cost-effectiveness of the implementation of [(68)Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging
por: van der Sar, Esmée C. A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mfci4g1ohmg0kg65p3sur4gvbk